Penn Medicine Heart and Vascular Center
B

Updates on the Diagnosis and Management of Amyloidosis

By Penn Medicine Heart and Vascular Center FEATURING Brian Drachman
August 16, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

32:57
Merck Oncology

Case Studies Discussion on R/R cHL: Treatment Selection for Certain …

Feat. W. Donnellan, L. Leslie

Featured Video

18:52
Merck Oncology

A Treatment Option for Certain Patients With Locally Advanced or Met…

Feat. C. Hoimes

Related Content

AUTOPLAY
ConvaTec
Risk Mitigation of Infection and Post-Operative Wound Complications …
Tue, Jul 28, 2020
Faculty: Charles Love , Theofanie Mela , ConvaTec , Bruce Wilkoff , Peter Belott
Boston Scientific
S-ICD as a first-line therapy: Results from the PRAETORIAN & UNTOUCH…
Thu, Nov 5, 2020
Faculty: Boston Scientific , Ulrika Birgersdotter-Green , Michael Gold , Reinoud Knops
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

19:30
Nasrien Ibrahim

Hot Topics in Heart Failure ACC.22

12:23
American Heart & Vascular Institute

SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Ho…

Feat. M. Tipton
21:36
NYU Langone

Emerging Therapies in Cardiac Amyloidosis

Feat. M. Hanna
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2…

Feat. B. Greenberg
16:31
Courage and Innovation Symposium: Heart Failure & Heart Transplantation

Cardiac Sarcoidosis: Improving Diagnosis and Management

Feat. B. Chung
14:44
26th Annual San Diego Heart Failure Symposium

Broadening Indications for the Use of Angiotensin Receptor Neprilysi…

Feat. C. Yancy
32:19
Medtronic

iATP: A New Anti-Tachycardia Pacing Algorithm

Feat. J. Cooper
18:58
Boston Scientific

Part 3 of 4: UNTOUCHED Trial Results

Feat. M. Gold, U. Birgersdotter-Green
03:01
BD

Patient Story: The use of Absorbable Hemostats to Control Bleeding i…

42:24
CVRx | Barostim

Barostim: Patient Identification and Real World Experience

Feat. M. Fudim, J. Singh, J. Allred
17:23
Northwestern Medicine: 8th Annual Cardiovascular Update

AF and Heart Failure: What’s the Risk? Is Ablation the Answer?

Feat. J. Piccini
64:40
CCM® Therapy

CCM® Therapy - Mechanism of Action, Patient Selection and Identifica…

Feat. A. Kaplan, H. Saltzman
25:43
Boston Scientific

S-ICD DFT & Impedance Review

61:12
CCM® Therapy

Assessing Heart Failure Patients - Where Does CCM® Therapy Fit

Feat. S. Brune, N. Bonnet, M. Arnold
06:09
CVRx | Barostim

The Need for New Device Therapies in HFrEF

Feat. J. Singh
18:36
Boston Scientific

Part 4 of 4: Q&A – PRAETORIAN & UNTOUCHED Trial Results

Feat. U. Birgersdotter-Green, M. Gold, R. Knops
05:13
Boston Scientific

Troubleshooting DFTs and S-ICD Case Studies

Feat. I. Almasry
15:15
ConvaTec

Prevention of CIED Infections: How Safe and (Cost)Effective Is the T…

Feat. B. Wilkoff
88:01
CCM® Therapy

The Comparison and Advantages of the Use of Device Therapy in Heart …

Feat. V. Thohan, G. Tomassoni, R. Doshi, F. Abi-Samra, I. Rao